• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FOSUN PHARMACEUTICALS USA MEDICAL SWAB; NASOPHARYNGEAL SWAB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FOSUN PHARMACEUTICALS USA MEDICAL SWAB; NASOPHARYNGEAL SWAB Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problems Cerebrospinal Fluid Leakage (1772); Laceration(s) (1946)
Event Type  Injury  
Event Description
This literature case, derived from a full text article, was received on 21-jan-2022.It described a (b)(6) year-old female patient in whom rhinorrhea was caused by a csf leakage (pt: cerebrospinal fluid leakage) post nasopharyngeal swab test for covid-19 (corona virus disease- 2019).Case report: a (b)(6) year-old woman presented with unilateral rhinorrhea on the right, progressive headache, and photophobia from a week ago.The patient had recently taken covid-19 nasopharyngeal swab test as she had contact with a positive covid-19 patient.Shortly after, she experienced rhinorrhea accompanied by a headache.She had no history of similar symptoms before.Her medical history was also negative for any types of surgery and illnesses.In physical examination, she had no abnormal findings other than clear rhinorrhea from the right side.The drained fluid was positive for beta-2 transferrin, proving that her rhinorrhea was caused by a cerebrospinal fluid (csf) leakage.She underwent contrast magnetic resonance venography with the suspicion of idiopathic intracranial hypertension, but the results were normal and lumbar puncture showed intracranial pressure (icp) of 11 mmhg.On computed tomography (ct) scan, there was not any obvious finding suggestive of a meningocele or skull base fracture.On cisternography, csf leakage was observed in right anterior ethmoid sinus.She was enlisted for an endoscopic surgical repair of the defect.Before the operation, intrathecal fluorescein was infused through a lumbar drain to visualize the csf leakage site during the operation.During the operation, the defect was sealed using fat and fascia lata.The patient's icp was measured two weeks and four weeks after the operation and was normal in both cases.In a follow-up visit two months after surgery, the patient was good and did not have any complaints.Author's comment: the case illustrated those individuals performing nasopharyngeal swab testing should do the test gently and take a brief history from patients regarding prior surgical intervention, or pathology that distorts normal nasal anatomy, before performing the test.This would reduce complications caused by this procedure and lower the risk of skull base erosions.Patients should be educated on different adverse events of nasopharyngeal swab testing and their associated symptoms.It was recommended that when performing a nasopharyngeal swab test, in case of any resistance, the healthcare staff should immediately stop the procedure and consider anatomical anomalies.An alternative test might be needed if nasopharyngeal test seems impossible.Literature citation: jafari a, samadian m, maroufi sf, taheri ms.Csf rhinorrhea after nasopharyngeal swab testing for covid-19: a case report and review of literature.Otolaryngol case rep.(b)(4).Company comment: a patient developed rhinorrhea caused by a csf leakage (cerebrospinal fluid leakage) post nasopharyngeal swab test for covid-19.In response to the event, patient underwent endoscopic surgical intervention.Considering the case information, the role of nasopharyngeal swab cannot be ruled out and the causality of cerebrospinal fluid leakage is assessed as possible with nasopharyngeal swab.The case is considered serious due to medical significance of cerebrospinal fluid leakage and required intervention.Cerebrospinal fluid leakage is unlisted as per uspi.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDICAL SWAB
Type of Device
NASOPHARYNGEAL SWAB
Manufacturer (Section D)
FOSUN PHARMACEUTICALS USA
suite 204
104 carnegie center
princeton NJ 08540
MDR Report Key13450354
MDR Text Key289273948
Report Number3015145560-2022-00001
Device Sequence Number1
Product Code KXG
Combination Product (y/n)N
Reporter Country CodeIR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/21/2022
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age47 YR
Patient SexFemale
-
-